Surgery
Conditions
Keywords
Acute normovolemic hemodilution, allogeneic transfusion
Brief summary
This study is aimed to determine if acute normovolemic hemodilution (ANH), an established blood conservation technique, reduces the requirement for allogeneic blood transfusion in operations with prediction of surgical bleeding over 20% of estimated blood volume (EBV)
Detailed description
Allogeneic blood transfusion is often done during surgery to save life- threatening conditions. Blood conservation is a method that can reduce peri-operative allogeneic blood transfusion. This study has been conducted on 34 patients underwent laparotomy surgery with bleeding more than 20% of EBV. After being informed concent, research subjects were randomized into two groups: ANH (conducted ANH) and control group (without ANH). After starting general anesthesia, the ANH group was withdrawing blood based on Gross formula. Restoration of circulated volume was instituted by infusion of colloids. In control group, the operation was started right after the induction of anesthesia. The monitoring of blood pressure, heart rate, the amount of bleeding, total fluid, urine production, hemoglobin concentration and number of allogenic transfusion were recorded.
Interventions
After general anesthesia is applied, blood was taken through the cubital vein and collected into standard blood bags containing CPDA anti-coagulant. The blood obtained is then stored at temperature of 23 - 25 Celsius degree and given back to patients in the operating room after the bleeding stopped and as soon as there are indications of transfusion.
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult patients scheduled for laparotomy under general anesthesia with potentially surgical bleeding \> 20% of EBV * ASA physical status I - II * hemoglobin level before surgery \> 11 g / dl for men and \> 10 g / dl for women
Exclusion criteria
* impaired coagulation (INR\> 1.5 and / or platelet count \<100,000) * active infection * disruption of metabolic liver * received anti fibrinolytic drugs
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduction of allogenic transfusion requirements | During surgery and 24 hours post surgery with target Hb > 8gr/dl | The investigators evaluate number of patients require allogenic transfusion during surgery until 24 hours post surgery with targeted haemoglobin level \> 8gr/dl. Blood pressure, heart rate, total bleeding, total fluid administration and urine production are also recorded in order to confirm that acute normovolemic haemodilution is safe in patients undergoing laparotomy surgery |
Countries
Indonesia